WOL

Grey Wolf

Stock
Stock
ISIN: CA3978851044
Ticker: WOLF
CA3978851044
WOLF

Price

Price

Frequently asked questions

What is Grey Wolf's market capitalization?

The market capitalization of Grey Wolf is $19.76M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Grey Wolf's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Grey Wolf is 85.00. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Grey Wolf?

Grey Wolf's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.007491. EPS indicates the company's profitability on a per-share basis.

What is Grey Wolf's revenue over the trailing twelve months?

Over the trailing twelve months, Grey Wolf reported a revenue of $18.18M.

What is the EBITDA for Grey Wolf?

Grey Wolf's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.97M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Grey Wolf?

Grey Wolf has a free cash flow of $562.25K. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the free float of Grey Wolf's shares?

The free float of Grey Wolf is 26.62M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$19.76M

EPS (TTM)

 
$0.007491

Free Float

 
26.62M

P/E ratio (TTM)

 
85.00

Revenue (TTM)

 
$18.18M

EBITDA (TTM)

 
$1.97M

Free Cashflow (TTM)

 
$562.25K

Pricing

52W span
$0.44$0.743

Information

Grey Wolf Animal Health Corp. is a Canadian diversified animal health company. The Company markets a portfolio of products that meets the unmet needs of veterinarians, clinics and pets. The Company operates two business units: Animal Health business unit and Pharmacy business unit. The Animal Health business unit focuses on sourcing, in-licensing, acquiring, and commercializing branded and generic pharmaceutical, nutraceutical, and consumable products for use in veterinary clinics across Canada. The Pharmacy business unit compounds pharmaceuticals, primarily for animal and human use, all based on prescriptions received from veterinarians, physicians, and patients. Its product categories include companion animals and equine health. The companion animal product category includes pharmaceuticals, wound care, nutraceuticals and disposables. Its equine health products include SUCCEED Digestive Conditioning Program, SUCCEED Equine Fecal Blood Test and Equi-Tape.

Retail (Specialty)

Consumer Discretionary

Identifier

ISIN

CA3978851044

Primary Ticker

WOLF
Join the conversation